MedTrace Logo

Genetic Assessment of the Patients With Metabolic Syndrome

NCT01268696 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2011-07-22

No results posted yet for this study

Summary

Metabolic syndrome is a combination of medical disorders that increase the risk of developing cardiovascular disease and diabetes. The exact mechanisms of the complex pathways of metabolic syndrome are not yet completely known. The pathophysiology is extremely complex and has been only partially elucidated. Most patients are older, obese, sedentary, and have a degree of insulin resistance. Stress can also be a contributing factor. The most important factors are:

weight, genetics, aging, sedentary lifestyle,excess caloric intake. In our study we will assess the role of some polymorphisms in the pathology of metabolic syndrome.

Conditions

  • Metabolic Syndrome

Sponsors & Collaborators

  • Medical University of Lodz

    lead OTHER

Principal Investigators

  • Tadeusz Pietrucha, prof. · Department of medical biotechnology

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-12-31
Primary Completion
2011-08-31
Completion
2015-01-31

Countries

  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01268696 on ClinicalTrials.gov